BenevolentAI | Investor Presentation Deck

Slide schematic 5/5

diagram 1/1 list 1/1 paragraph 1/1 title 2/2

Components 5

process bullet paragraph headline subtitle

Tools 1

list/bullet: 5+ years of experience building highly specific, biopharma sector and domain specialised LLMs and AI models for use across R&D. Leverages our core competencies in drug discovery and data integration. Capital

Metrics 0

∅

No metrics

No metric insight is anchored to this slide.

Frameworks 1

before-after-bridge 80%

Connects market evolution (before/current state) to company strategy (bridge/future state).

Find anything

Uses a simple causal flow from market shift to company strategy.